Skip to content
Brand AI

Veloxis Pharmaceuticals

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Xenikos closes €40 million convertible debt financing

    Xenikos announced the closing of €40 million in convertible debt financing, led by Veloxis Pharmaceuticals, with participation from existing investors. In connection with the financing, Veloxis was to obtain two sequential call options to acquire Xenikos and a board seat.

    Source